Medicines For Europe’s Sieger: ‘We Have To Create An Ecosystem Where We Can Compete’
Generics Bulletin Hosts Exclusive Interview With Association VP And Polpharma CEO
Markus Sieger, vice-president of off-patent industry association Medicines for Europe and CEO of Polpharma, spoke to Generics Bulletin about critical issues affecting supply in Europe, including pricing, supply chains, and his enthusiasm for ESG.